A federal court has entered a $3,423,389.84 default judgment against a Nebraska pharmacist and pharmacy operator over alleged false claims submitted to Medicare and Medicaid. The U.S. District Court for the District of Nebraska entered the judgment May 29 against…
Pharmacy
Jacksonville, Fla.-based Baptist Health has partnered with Shields Health Solutions to launch an integrated specialty pharmacy program aimed at improving access to medications for patients with chronic and complex conditions. The new Baptist Specialty Pharmacy, located at Baptist MD Anderson…
Pharmacy leaders have watched pay gaps widen across states for years — and new data puts hard numbers on what that looks like in practice. Nationally, pharmacists earned a mean annual salary of approximately $140,180 in 2025, while technicians earned…
Eli Lilly’s deadline for hospitals to submit claims data or lose 340B drug discounts has passed, and with HHS’ Health Resources and Services Administration silent on requests from hospital and pharmacy groups to intervene, noncompliant hospitals are exposed. Lilly sent…
Health systems today are under pressure to do more with less. They need to expand access, improve patient care, and manage increasingly complex medication supply chains with fewer staff, tighter operating margins, limited physical space, and increasing regulatory and reimbursement…
Advertisement
TrumpRx.gov is adding 160 prescription drugs to the platform, bringing its total to more than 800 according to a June 5 Truth Social post from President Donald Trump. The president said the expansion would allow TrumpRx.gov to offer discounted pricing…
The FDA has expanded approval of a hemophilia treatment developed by Pfizer to include pediatric patients ages 6-11 with or without inhibitors and for patients 12 and older with inhibitors. The expanded indication covers routine prophylaxis to prevent or reduce…
A federal judge has dismissed with prejudice AbbVie’s lawsuit challenging Mississippi’s Defending Affordable Prescription Drug Costs Act, granting summary judgment to Mississippi Attorney General Lynn Fitch, according to a June 3 final judgment. AbbVie and several affiliated companies sued Mississippi…
Drugmakers, patient advocates and public health experts have urged the FDA to pause or significantly revise its priority voucher program during the agency’s first public hearing on the initiative June 4. Critics cited concerns about transparency, political influence and the…
The FDA’s Center for Drug Evaluation and Research has accepted the first letter of intent for an in silico drug development tool into the agency’s Innovative Science and Technology Approaches for New Drugs qualification program. The tool, an AI-Driven Digital…